Isacco Ferrarini

Hematology Unit, Section of Biomedicine of Innovation, Department of Engineering for Innovation Medicine, University of Verona, Italy

N/A

Poster(s):

• 1435 - Absence of lymphocytosis after starting treatment with cBTKi is a rare phenomenon except for trisomy 12 and CD49d positive CLL

• 1602 - Venetoclax in combination with chemotherapy in Richter Syndrome patients: a real-life experience